Algeria vs Burkina Faso: Access to anti-retroviral drugs, male
Algeria
68.0%
in 2024
Burkina Faso
68.0%
in 2024
Algeria rank
73rd
Burkina Faso rank
73rd
Access to anti-retroviral drugs, male over time
- Algeria
- Burkina Faso
How they compare
Algeria currently reports 68.0% against 68.0% in Burkina Faso, a difference of 0.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Algeria ahead.
Algeria ranks 73rd and Burkina Faso ranks 73rd of 141 countries.
Algeria has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Algeria | Burkina Faso | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.3% | 9.1% | 4.2% | Algeria |
| 2010s | 42.6% | 40.3% | 2.3% | Algeria |
| 2020s | 69.6% | 60.8% | 8.8% | Algeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Algeria or Burkina Faso?
- Algeria, at 68.0% against 68.0% in Burkina Faso as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Algeria and Burkina Faso?
- 0.0%, with Algeria ahead.
- How many years of comparable data are there for Algeria and Burkina Faso?
- 25 years are reported by both, from 2000 to 2024.
- How do Algeria and Burkina Faso rank globally for access to anti-retroviral drugs, male?
- Algeria ranks 73rd and Burkina Faso ranks 73rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.